Overview

A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Status:
Completed

Trial end date:
2019-12-17

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to evaluate the pharmacokinetic (PK) profile of AMG 510 administered alone and in combination with itraconazole in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Amgen

Treatments:

Itraconazole